Experts discuss abstracts from the 2026 ASCO Annual Meeting that may represent critical advances across multiple myeloma, leukemia, and lymphoma.
Sofia Zahid, MD
Advertisement
Articles by Sofia Zahid, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Navigating the RCC Adjuvant Landscape: Examining the Phase 3 RAMPART Trial
2
Radiation Oncology Trials You May Have Missed at ASCO 2026
3
84 Exceptional Responders in De Novo Metastatic Breast Cancer (dnMBC) Drug Cessation in Patients With HER2-Positive Metastatic Breast Cancer; Multicenter Retrospective Study
4
BCMA CAR T-Cell Therapy Improves OS Vs Teclistamab in Multiple Myeloma
5